New Jersey Institute of Technology remains ever-present in ROI-NJ’s 2021 Power Lists of ROI Influencers in New Jersey. Ten Highlanders appear in seven categories: the Best in Higher Education,Technology Experts, Top Executives, Top Lawyers, Elected Officials; Association, Organizational and Nonprofit Leaders; and Top 30 ROI Influencers in the state. 

Today the Biopharma Division of the New Jersey Innovation Institute (NJII), an NJIT corporation, introduced BioCentriq as the name of its cell and gene therapy production and manufacturing center. BioCentriq is the only process development and clinical manufacturing facility for cell and gene therapies located in Newark, N.J., and the first of its kind to be located on a university campus in the United States.

The New Jersey Innovation Institute’s (NJII) Biopharma division is pleased to announce the formation of their advisory committee which includes experts from across the industry.

The committee will meet quarterly and provide strategic direction to the division as well as help identify emerging opportunities and challenges in the area of regenerative medicine.

New Jersey Institute of Technology (NJIT) in collaboration with New Jersey Innovation Institute (NJII), an NJIT corporation, has announced it will soon offer both a Professional Science Masters (PSM) degree program and professional graduate certificate in the rapidly expanding field of cell and gene therapy.

The focus of the event was why New Jersey is the best place for entrepreneurs and businesses in the U.S., as well for foreign firms seeking to enter the U.S. market, to invest in and grow their businesses. And the interest in doing so was indeed high, with upward of 150 people from over 40 industries — from accounting and architecture, to insurance and investment, to manufacturing and marketing and more — attending the inaugural ExploreNJ conference.